News & Updates

Show Multimedia Only
Salbutamol may lower risk, improve prognosis of prostate cancer Salbutamol may lower risk, improve prognosis of prostate cancer

Salbutamol may lower risk, improve prognosis of prostate cancer

14 Dec 2024

The incidence of prostate cancer is reduced among individuals treated with salbutamol, a short-acting beta-2 adrenergic agonist, according to a study.

14 Dec 2024
Metformin improves responses to chemotherapy in nondiabetic breast cancer

Metformin improves responses to chemotherapy in nondiabetic breast cancer

11 Dec 2024

Use of metformin in nondiabetic breast cancer patients improves their clinical and pathological response to neoadjuvant AC-T chemotherapy, reveals a recent study.

11 Dec 2024